Fingerprint Dive into the research topics where Neurosurgery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Glioblastoma Medicine & Life Sciences
Glioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Stroke Medicine & Life Sciences
Lipoma Medicine & Life Sciences
Meningioma Medicine & Life Sciences
Temporal Lobe Epilepsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2020

A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient

Fujioka, Y., Hata, N., Hatae, R., Suzuki, S. O., Sangatsuda, Y., Nakahara, Y., Mizoguchi, M. & Iihara, K., Feb 1 2020, In : Neuropathology. 40, 1, p. 99-103 5 p.

Research output: Contribution to journalArticle

Glioma
temozolomide
Molecular Pathology
Thalamus
Hippocampus

Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: A retrospective study by the Japan Children’s Cancer Group

Yamasaki, K., Kiyotani, C., Terashima, K., Watanabe, Y., Kanamori, M., Koga, Y., Hata, N., Iwasaki, F., Goto, H., Koh, K., Kurihara, J., Tokunaga, S., Arakawa, Y., Hasegawa, D., Kosaka, Y. & Hara, J., Jan 1 2020, In : Journal of Neurosurgery: Pediatrics. 25, 2, p. 111-120 10 p.

Research output: Contribution to journalArticle

Japan
Retrospective Studies
Pediatrics
Survival
Craniospinal Irradiation

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

Hata, N., Mizoguchi, M., Kuga, D., Hatae, R., Akagi, Y., Sangatsuda, Y., Amemiya, T., Michiwaki, Y., Fujioka, Y., Takigawa, K., Suzuki, S. O., Yoshitake, T., Togao, O., Hiwatashi, A., Yoshimoto, K. & Iihara, K., Feb 1 2020, In : Journal of Neuro-Oncology. 146, 3, p. 451-458 8 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Survival
Methylation
Bevacizumab